Angiotensin receptor neprilysin inhibitor in inotrope dependent heart failure patients: A case series [PDF]
Journal of Cardiovascular and Thoracic Research, 2020 Patients with advanced heart failure (HF) symptoms constitute stage D heart failure with high mortality and less response to conventional guideline directed medical therapies.
Sepideh Taghavi +4 more
doaj +2 more sources
Strong Association between Inotrope Administration and Intraventricular Hemorrhage, Gestational Age, and the Use of Fentanyl in Very Low Gestational Age Infants: A Retrospective Study [PDF]
Children, 2023 This was a single center, retrospective cohort study designed to evaluate the association between the administration of inotropes to hypotensive very low gestational age infants (VLGAI) and prenatal and neonatal risk factors.
Theodora Stathopoulou +5 more
doaj +2 more sources
Why has positive inotropy failed in chronic heart failure? Lessons from prior inotrope trials. [PDF]
, 2019 Current pharmacological therapies for heart failure with reduced ejection fraction are largely either repurposed anti-hypertensives that blunt overactivation of the neurohormonal system or diuretics that decrease congestion.
Ahmad, T +10 more
core +4 more sources
JACC: Heart Failure, 2018 I have read with interest a recent meta-analysis by Nizamic et al. [(1)][1] of inotropes in heart failure. The authors concluded that inotropes improve functional status but do not impact survival.
Maya Guglin
openaire +4 more sources
Inotropes and cardiorenal syndrome in acute heart failure – A retrospective comparative analysis
Revista Portuguesa de Cardiologia, 2017 Introduction: Cardiorenal syndrome (CRS) is common in acute heart failure (AHF), and is associated with dire prognosis. Levosimendan, a positive inotrope that also has diuretic effects, may improve patients’ renal profile.
Marta Madeira +6 more
doaj +2 more sources
Hearts, 2021 Background and Aims: We hypothesized that maintaining a patient on moderate–high doses of potent inhalational agent for greater than 30 min during the post-bypass period would be an independent predictor of initiation and usage of either inotropic and/or
Tara A. Lenk +6 more
doaj +1 more source
Frontiers in Cardiovascular Medicine, 2021 Purpose: To determine whether inotrope administration is associated with increased all-cause mortality in cardiogenic shock (CS) patients and to identify inotropes superior for improving mortality.Methods: This retrospective cohort study analyzed data ...
Fei Gao, Yun Zhang
doaj +1 more source
Post‐transplant inotrope score is associated with clinical outcomes after adult heart transplantation [PDF]
, 2021 Background: Inotrope score has been proposed as a marker of clinical outcome after adult heart transplantation (HTx) but is rarely used in practice.
Damman, Kevin +4 more
core +1 more source
Cost-effectiveness of left ventricular assist devices (LVADs) for patients with advanced heart failure : analysis of the British NHS Bridge to Transplant (BTT) program [PDF]
, 2001 Background: A previous cost-effectiveness analysis showed that bridge to transplant (BTT) with early design left ventricular assist devices (LVADs) for advanced heart failure was more expensive than medical management while appearing less beneficial ...
Aileen Clarke +33 more
core +7 more sources
State of Shock: Contemporary Vasopressor and Inotrope Use in Cardiogenic Shock
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2023 Cardiogenic shock is characterized by tissue hypoxia caused by circulatory failure arising from inadequate cardiac output. In addition to treating the pathologic process causing impaired cardiac function, prompt hemodynamic support is essential to reduce
Jason E. Bloom +3 more
doaj +1 more source